ASCO: GLP-1 Receptor Agonist Initiation Cuts Metastatic Progression

Here are some articles that actually mentioned prostate cancer and GLP-1. Mostly in relation to Having fewer people get prostate cancer and fewer metastasis.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11479428/
ASCO highlighted four studies — some of which were published in its affiliated Journal of Clinical Oncology. The most prominent among them tracked medical and prescription records of over 10,000 patients with early-stage cancer, and found GLP-1s reduced cancer risk in 6 out of 7 cancers — four of them at statistically significant levels. Breast, liver, colorectal and non-small cell lung cancer risks declined significantly; kidney and prostate declined somewhat; pancreatic cancer rates were affected the least.
https://www.asco.org/about-asco/press-center/glp-may-reduce-metastatic-progression

@jeffmarc

Yes, it applies to PC also , that is why I posted it : ))). 👍 I am terribly busy today so did not have time to type additional info and links , I apologize and thanks for pointing it out so that other know why it is posted here 💗.

PS: How are you doing today : ))) ?! I hope that progress is fast and pain much less prominent. 🍀

@surftohealth88
I am doing quite good. I can’t sit on everything but it’s getting a lot more comfortable.

I only posted more because the first link you put in didn’t have the word prostate in it.

@jeffmarc

"I am doing quite good. I can’t sit on everything but it’s getting a lot more comfortable. "

That is really great to hear 😊👍 ! You always heal extra fast and I have no doubt that very soon you will be "like new" 🍀

Now you tell me. Could have save a lot of trouble just taking a GLP1 rather than the ADT. However, doubt the GLP1 is as effective. They are really good at controlling glucose and weight.

@jim18
It does not look as effective. It appears that it slows growth doesn’t stop it like ADT or the patch.